泓博医药：关于更换保荐代表人的公告

Core Viewpoint - Hongbo Pharmaceutical announced a change in its continuous supervision representative for its initial public offering on the ChiNext board, with Citic Securities as the sponsor [1] Group 1 - Citic Securities was originally represented by Wang Qi and Li Song for the continuous supervision of Hongbo Pharmaceutical [1] - Due to personal work adjustments, Wang Qi will no longer serve as the continuous supervision representative [1] - Yuan Binlong has been appointed to continue the supervision work until the statutory supervision period ends on December 31, 2025 [1]